The inactive X chromosome (Xi) in female mammals serves as an important model for studying the role of histone isoforms in directing specific nuclear processes leading to inherited differences in transcription. In the present study, we investigated the distribution of some histone isoforms known to be involved in the process of human X inactivation on their bovine counterparts. To ascertain the identity of active and inactive X chromosome, their distribution was investigated on the X chromosomes in a cell line derived from a bovine female carrying an X;autosome translocation rcp(Xp+;23q–) which allowed the recognition of the maternal (translocated) and paternal (normal) X chromosome. The distribution patterns of histone H3 trimethylated at lysine 9 (H3K9me3) and trimethylated at lysine 27 (H3K27me3), and histone macroH2A1 and macroH2A2 (isoforms specific to heterochromatin) were determined by immunocytochemistry and compared to the temporal pattern of replication using BrdU pulse labeling prior to staining. Immunostaining revealed that H3K9me3, H3K27me3, and macroH2A1 are preferentially concentrated on the Xi, whereas the histone variant macroH2A2 is not a marker for this chromosome. H3K9me3, H3K27me3, and macroH2A1 were consistently located in bands along the Xi, while H3K9me3, macroH2A1 and macroH2A2 localized in the pericentromeric regions of the autosomes. H3K27me3 identified two intense bands on the Xi at Xp22 and Xq31, representing the early replication regions of the chromosome. H3K27me3 and macroH2A1 overlapped in the Xq31 region. It was concluded that different heterochromatin regions on the bovine inactive X chromosome can be identified by their histone isoform composition.

Keywords:
Bovine, Histone modifications, Histone variants, X inactivation
1.
Amaral MEJ, Kata SR, Womack JE: A radiation hybrid map of bovine X chromosome (BTAX). Mamm Genome 13:268–271 (2002).
2.
Arney KL, Fisher AG: Epigenetic aspects of differentiation. J Cell Sci 117:4355–4363 (2004).
3.
Ausio J, Abbott DW, Wang X, Moore SC: Histone variants and histone modifications: a structural perspective. Biochem Cell Biol 79:693–708 (2001).
4.
Basrur PK, Pinheiro LE, Berepubo NA, Reyes ER, Popescu PC: X chromosome inactivation in X-autosome translocation carrier cows. Genome 35:667–675 (1992).
5.
Basrur PK, Koykul W, Baguma-Nibasheka M, King WA, Ambady S, Ponce de Leon FA: Synaptic pattern of sex complements and sperm head malformation in X-autosome translocation carrier bulls. Mol Reprod Dev 59:67–77 (2001).
6.
Basrur PK, Farazmand A, Stranzinger G, Graphodatskaya D, Reyes ER, King WA: Expression pattern of X-linked genes in sex chromosome aneuploid bovine cells. Chromosome Res 12:263–273 (2004).
7.
Belyaev ND, Keohane AM, Turner BM: Differential underacetylation of histone H2A, H3 and H4 on the inactive X chromosome in human female cells. Hum Genet 97:573–578 (1996).
8.
Boggs BA, Connors B, Sobel RE, Chinault AC, Allis CD: Reduced levels of histone H3 acetylation on the inactive X chromosome in human females. Chromosoma 105:303–309 (1996).
9.
Brinkman AB, Roelofsen T, Pennings SW, Martens JH, Jenuwein T, Stunnenberg HG: Histone modification patterns associated with the human X chromosome. EMBO Rep 7:628–634 (2006).
10.
Brockdorff N, Ashworth A, Kay GF, McCabe VM, Norris DP, et al: The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 71:515–526 (1992).
11.
Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, et al: A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349:38–44 (1991).
12.
Carrel L, Cottle AA, Goglin KC, Willard HF: A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci USA 96:14440–14444 (1999).
13.
Chadwick BP: Variation in Xi chromatin organization and correlation of the H3K27me3 chromatin territories to transcribed sequences by microarray analysis. Chromosoma 116:147–157 (2007).
14.
Chadwick BP, Willard HF: Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant. Hum Mol Genet 10:1101–1113 (2001).
15.
Chadwick BP, Willard HF: Cell cycle-dependent localization of macroH2A in chromatin of the inactive X chromosome. J Cell Biol 157:1113–1123 (2002).
16.
Chadwick BP, Willard HF: Multiple spatially distinct types of facultative heterochromatin on the human inactive X chromosome. Proc Natl Acad Sci USA 101:17450–17455 (2004).
17.
Cheung P, Lau P: Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 19:563–573 (2005).
18.
Chow JC, Yen Z, Ziesche SM, Brown CJ: Silencing of the mammalian X chromosome. Annu Rev Genomics Hum Genet 6:69–92 (2005).
19.
Costanzi C, Pehrson JR: Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393:599–601 (1998).
20.
Costanzi C, Pehrson JR: MACROH2A2, a new member of the MACROH2A core histone family. J Biol Chem 276:21776–21784 (2001).
21.
Cowell IG, Aucott R, Mahadevaiah SK, Burgoyne PS, Huskisson N, et al: Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals. Chromosoma 111:22–36 (2002).
22.
Di Berardino D, Coppola G, Verdoliva C, Coppola GF, Ramunno L, et al: Onset and sequence of RBA-band replication on the inactive X-chromosomes of cattle (Bos taurus L.), river buffalo (Bubalus bubalis L.) and goat (Capra hircus L.). Chromosome Res 10:637–643 (2002).
23.
Duthie SM, Nesterova TB, Formstone EJ, Keohane AM, Turner BM, et al: Xist RNA exhibits a banded localization on the inactive X chromosome and is excluded from autosomal material in cis. Hum Mol Reprod 8:195–204 (1999).
24.
Gilbert CW, Muldal S, Lajtha LG, Rowley J: Time-sequence of human chromosome duplication. Nature 195:869–873 (1962).
25.
Goldammer T, Amaral MEJ, Brunner RM, Owens E, Kata SR, et al: Clarifications on breakpoints in HSAX and BTAX by comparative mapping of F9, HPRT and XIST in cattle. Cytogenet Genome Res 101:39–42 (2003).
26.
Hansen RS, Canfield TK, Fjeld AD, Gartler SM: Role of late replication timing in the silencing of X-linked genes. Hum Mol Genet 5:1345–1353 (1996).
27.
Heard E: Recent advances in X-chromosome inactivation. Curr Opin Cell Biol 16:247–255 (2004).
28.
Jenuwein T, Allis CD: Translating the histone code. Science 294:2477 (2001).
29.
Jeppesen P, Turner BM: The inactive-X chromosome in female mammals is distinguished by a lack of H4 acetylation, a cytogenetic marker for gene expression. Cell 74:281–289 (1993).
30.
Kamakaka RT, Biggins S: Histone variants: deviants? Genes Dev 19:295–310 (2005).
31.
Lakshmi B, Hall IM, Egan C, Alexander J, Leotta A, et al: Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens. Proc Natl Acad Sci USA 103:11234–11239 (2006).
32.
Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ: Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389:252–260 (1997).
33.
Lyon MF: Gene action in the X-chromosome of the mouse (Mus musculus L.).Nature 190:372–373 (1961).
34.
Mattei MG, Mattei JF, Aymé S, Giraud F: X-autosome translocations: Cytogenetic characteristics and their consequences. Hum Genet 61:295–309 (1982).
35.
McManus KJ, Biron VL, Heit R, Underhill DA, Hendzel MJ: Dynamic changes in histone H3 lysine 9 methylations: identification of a mitosis-specific function for dynamic methylation in chromosome congression and segregation. J Biol Chem 281:8888–8897 (2006).
36.
Mermoud JE, Costanzi C, Pehrson JR, Brockdorff N: Histone macroH2A1.2 relocates to the inactive X chromosome after initiation and propagation of X-inactivation. J Cell Biol 147:1399–1408 (1999).
37.
Mohandas T, Sparkes RS, Shapiro LJ: Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211:393–396 (1981).
38.
Nino-Soto MI, Nuber UA, Basrur PK, Ropers HH, King WA: Differences in the pattern of X-linked gene expression between fetal bovine muscle and fibroblast cultures derived from the same muscle biopsies. Cytogenet Genome Res 111:57–64 (2005).
39.
Nino-Soto MI, Basrur PK, King WA: Impact of in vitro production techniques on the expression of X-linked genes in bovine (Bos taurus) oocytes and pre-attachment embryos. Mol Reprod Dev 74:144–153 (2007).
40.
Nolen LD, Gao S, Han Z, Mann MR, Gie Chung Y, et al: X chromosome reactivation and regulation in cloned embryos. Dev Biol 279:525–540 (2005).
41.
Pathak S, Kieffer NM: Sterility in hybrid cattle. I. Distribution of constitutive heterochromatin and nucleolus organizer regions in somatic and meiotic chromosomes. Cytogenet Cell Genet 24:42–52 (1979).
42.
Pehrson JR, Fried VA: MacroH2A, a core histone containing a large nonhistone region. Science 257:1398–1400 (1992).
43.
Peippo J, Farazmand A, Kurkilahti M, Markkula M, Basrur PK, King WA: Sex-chromosome linked gene expression in in-vitro produced bovine embryos. Mol Hum Reprod 8:923–929 (2002).
44.
Peterson CL, Laniel MA: Histones and histone modifications. Curr Biol 14:546–551 (2004).
45.
Pfeifer GP, Tanguay RL, Steigerwald SD, Riggs AD: In vivo foot-print and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1. Genes Dev 4:1277–1287 (1990).
46.
Ponce de Leon FA, Ambady S, Hawkins GA, Kappes SM, Bishop MD, et al: Development of a bovine X chromosome linkage group and painting probes to assess cattle, sheep, and goat X chromosome segment homologies. Proc Natl Acad Sci USA 93:3450–3454 (1996).
47.
Rasmussen TP, Huang T, Mastrangelo MA, Loring J, Panning B, Jaenisch R: Messenger RNAs encoding mouse histone macroH2A1 isoforms are expressed at similar levels in male and female cells and result from alternative splicing. Nucleic Acids Res 27:3685–3689 (1999).
48.
Santos F, Dean W: Epigenetic reprogramming during early development in mammals. Reproduction 127:643–651 (2004).
49.
Schmidt M, Du Sart D: Functional disomies of the X chromosome influence the cell selection and hence the inactivation pattern in females with balanced X;autosome translocations: a review of 122 cases. Am J Med Genet 42:161–169 (1992).
50.
Smith KP, Byron M, Clemson CM, Lawrence JB: Ubiquitinated proteins including uH2A on the human and mouse inactive X chromosome: enrichment in gene rich bands. Chromosoma 113:324–335 (2004).
51.
Spector DL, Goldman RD, Leinwand LA: Cells: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1998).
52.
Spotswood HT, Turner BM: An increasingly complex code. J Clin Invest 110:577–582 (2002).
53.
Strahl BD, Allis CD: The language of covalent histone modifications. Nature 403:41–45 (2000).
54.
Turner JM: Meiotic sex chromosome inactivation. Development 134:1823–1831 (2007).
55.
Wolff DJ, Carrel L, Kelly CL, Willard HF, Schwartz S: Correlation of X inactivation pattern with phenotype in females with an abnormal phenotype. Am J Hum Genet 59 (suppl):A99 (1996).
56.
Wolffe AP, Pruss D: Deviant nucleosomes: the functional specialization of chromatin. Trends Genet 12:58–62 (1996).
57.
Wrenzycki C, Lucas-Hahn A, Herrmann D, Lemme E, Korsawe K, Niemann H: In vitro production and nuclear transfer affect dosage compensation of the X-linked gene transcripts G6PD, PGK, and Xist in preimplantation bovine embryos. Biol Reprod 66:127–134 (2002).
58.
Xue F, Tian XC, Du F, Kubota C, Taneja M, et al: Aberrant patterns of X chromosome inactivation in bovine clones. Nat Genet 31:216–220 (2002).
59.
Zuffardi O: Cytogenetics of human X/autosome translocations, in Sandberg AA (ed): Cytogenetics of the Mammalian X Chromosome, Part B: Basic Mechanisms of X Chromosome Behaviour, pp 193–210 (Alan R. Liss, New York 1983).
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.